a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.
Industry Biotechnology
A.I.dvisor tells us that PSTV and CRSP have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PSTV and CRSP's prices will move in lockstep.
Ticker / NAME | Correlation To PSTV | 1D Price Change % | ||
---|---|---|---|---|
PSTV | 100% | -3.82% | ||
CRSP - PSTV | 25% Poorly correlated | -5.90% | ||
ASND - PSTV | 24% Poorly correlated | -1.39% | ||
LYEL - PSTV | 24% Poorly correlated | N/A | ||
ALZN - PSTV | 24% Poorly correlated | +0.69% | ||
GLPG - PSTV | 23% Poorly correlated | +1.23% | ||
More |